NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.0960
-0.0040 (-4.00%)
Mar 4, 2026, 3:14 PM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 33.26 million as of March 4, 2026. Its market cap has increased by 505.23% in one year.
Market Cap
33.26M
Enterprise Value
26.90M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 33.26M, an increase of 100.88%. That is a compound annual growth rate of 9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 33.26M | -9.09% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 71.50M |
| Neurizon Therapeutics | 63.35M |
| Amplia Therapeutics | 61.57M |
| Proteomics International Laboratories | 56.16M |
| Entropy Neurodynamics | 54.87M |
| Avecho Biotechnology | 33.06M |
| Algorae Pharmaceuticals | 29.03M |
| Argenica Therapeutics | 28.26M |